Chris Grashoff

Chris Grashoff leads the Ambulatory Infusion Suite strategy including the execution of over 140+ locations, the Nursing Network of SPNN and Infinity Infusion Nursing, as well as New Business Ventures. Chris also led the integration of the merger between Option Care Health and BioScrip in 2019. He has over 20 years of global healthcare experience in leadership positions with a demonstrated history of advancing patient-centric healthcare solutions in provider services, medical devices and pharma for both developed and emerging markets.

Chris’ breadth of leadership experience includes positions in general management, strategy, business development, marketing and finance. Prior to Option Care Health, he spent nearly 12 years at Baxter International leading global businesses in renal care services, hemodialysis and peritoneal dialysis that included living in Sweden as the Global Franchise Head for In-Center Hemodialysis following Baxter’s acquisition of Gambro. He began his career in finance at Eli Lilly & Co.

Chris earned his Bachelor of Arts degree in Economics and Management from DePauw University and his MBA from Harvard Business School.